Protect Your Benefits from Devastating Pharma Ads

In this episode of the ASHHRA podcast, Kyra Hagan, SVP of Marketing at RxBenefits, unpacks the impact of the $6 billion direct-to-consumer pharmaceutical advertising machine.   

Aggressive marketing drives members to request high-cost, brand-name medications, creating financial strain for health plans. Chronic conditions like arthritis, diabetes, and autoimmune disorders are often the target, with GLP-1s also exploding into a massive market.  

To protect employee benefits while containing rising costs, HR leaders should:   

• Proactively audit PBM relationships to ensure aligned incentives  
• Require independent clinical oversight from pharmacy partners  
• Leverage data analytics to identify spending trends early  
• Educate members on DTC drug advertising and cost-effective alternatives   

Listen to the full podcast episode to learn more.